Caristo Applauds Abcentra for Successful Phase 2b Trial Start
‘FORTIFY’ Selects FAI-Score™ as Primary Outcome Measure, and Caristo as Worldwide Imaging Core Lab for Coronary Inflammation and Plaque Measurement and Monitoring Caristo Diagnostics, on a mission...